PMID: 8447521Feb 1, 1993Paper

Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis

The American Journal of Tropical Medicine and Hygiene
Y Martin-PrevelM Pinder

Abstract

A study was carried out in southeastern Gabon to evaluate the tolerance and efficacy of single high doses of ivermectin in 31 Loa loa-infected subjects with low-to-moderate parasitemia (7-7,700 microfilaria/ml). The first group of 16 subjects received 300 micrograms/kg of ivermectin and, seven days later, a second group of 15 received 400 micrograms/kg. Complete clinical and biological monitoring was carried out during the first 10 days post-treatment and again after one and three months. All subjects continued with their usual activities during the study. The clinical tolerance of treatment was very good, and except in one case, only mild adverse reactions were observed, with pruritus being the most common symptom. There were no significant changes in blood or urine function test results or in hematologic results, except for a pronounced eosinophil reaction. The 400 micrograms/kg dose of ivermectin equaled or surpassed in tolerance that of 300 micrograms/kg dose. After treatment, L. loa microfilaremia decreased rapidly to less than 9% of the pretreatment value by day 10. This decrease was enhanced with the 400 micrograms/kg dose, although differences between the two groups diminished slightly with time. At 100 days post-treatm...Continue Reading

Citations

Dec 16, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·J P ChippauxM Demanou
Sep 6, 2000·The British Journal of Dermatology·B Leppard, A E Naburi
Nov 21, 2000·Pediatric Dermatology·S C CestariM M Alchorne
Sep 3, 2003·Tropical Medicine & International Health : TM & IH·Nana A Y Twum-Danso, Stefanie E O Meredith
Feb 17, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·T H DuongD Richard-Lenoble
May 2, 1996·The New England Journal of Medicine·L X Liu, P F Weller
Aug 28, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·A MorroneM Marangi
Jan 18, 2007·Annals of Tropical Medicine and Parasitology·M Boussinesq
Mar 20, 2008·Annals of Tropical Medicine and Parasitology·G O AdeoyeE I Braide
Jun 29, 2010·The Journal of Clinical Pediatric Dentistry·Akhilesh Sharma, Amitha Hedge
Aug 20, 2019·BMC Pharmacology & Toxicology·Jean-Claude Makenga BofYves Coppieters
Jul 6, 1995·The New England Journal of Medicine·T L MeinkingF A Kerdel
Jul 24, 2001·Drugs·T C RoosD R Bickers
Jul 12, 2005·Annals of Tropical Medicine and Parasitology·S D S PionM Boussinesq
Jul 9, 2011·The Korean Journal of Parasitology·A A HassanF O Owagboriaye
Jul 17, 2019·Emerging Infectious Diseases·Federico GobbiZeno Bisoffi
Jun 13, 2002·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·J Stammen, M Klüppel
Jan 1, 1994·International Ophthalmology·S N CousensB R Jones
Feb 5, 2009·Expert Opinion on Pharmacotherapy·Erwin van den Enden
Aug 13, 2005·The Journal of Dermatological Treatment·Fernando de Andrade Quintanilha RibeiroClaudia A Eckley
Aug 24, 2004·Brazilian Dental Journal·Elio Hitoshi ShinoharaAndré Takahashi
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jesica A HerrickAmy D Klion
Jul 9, 2017·Malaria Journal·Kevin C KobylinskiJason H Richardson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.